Шолпан Садыкова | Health Professions | Best Researcher Award

Published on by Citation Awards

Best Researcher Award

Research Information
Researcher Шолпан Садыкова
Affiliation КазНУ им. аль-Фараби
Country Kazakhstan
Scopus ID 59674543700
Documents 4
Citations 2
h-index 1
Subject Area Health Professions
Event International Research Excellence and Citation Awards
ORCID 0009-0008-8524-4034

Шолпан Садыкова
КазНУ им. аль-Фараби, Kazakhstan

The Шолпан Садыкова, highlighting academic affiliation, publication metrics, research contributions, and relevance to the International Research Excellence and Citation Awards. The information presented follows a neutral encyclopedic style based on publicly available academic profile data.[1]

Abstract

This article provides a concise academic overview of Шолпан Садыкова, whose scholarly activity is indexed in Scopus within the Health Professions subject area. The profile demonstrates participation in peer-reviewed research and contributes measurable scholarly output appropriate for consideration in research recognition programs.[1]

Keywords

Best Researcher Award, Health Professions, Scopus, Academic Recognition, Research Excellence, Kazakhstan, Citation Impact, Scientific Publications.

Introduction

Academic awards acknowledge consistent scholarly productivity, ethical research practices, and contributions that strengthen scientific knowledge. Evaluation frequently incorporates publication quality, citation indicators, institutional affiliation, and participation in recognized indexing services.[2]

Research Profile

Шолпан Садыкова is affiliated with КазНУ им. аль-Фараби in Kazakhstan. According to the provided Scopus profile, the researcher has authored four indexed documents with two citations and an h-index of one. The primary indexed discipline is Health Professions, reflecting participation in health-related scholarly research.[1]

Research Contributions

The available publication metrics indicate continuing engagement with peer-reviewed scientific communication. Indexed publications contribute to evidence dissemination, interdisciplinary collaboration, and cumulative academic knowledge. Citation performance provides an additional indicator of scholarly visibility within the research community.[1]

Publications

Research Impact

Research impact is commonly evaluated using publication volume, citation frequency, indexing quality, and scholarly influence. The available metrics indicate an emerging publication profile that demonstrates participation in internationally indexed research and provides a measurable foundation for future academic development.[1]

Award Suitability

Based on the available scholarly indicators, the researcher demonstrates characteristics commonly considered during academic award evaluations, including peer-reviewed publications, indexed research output, institutional affiliation, and documented citation activity. Final award decisions should additionally consider research quality, originality, ethics, and overall contribution to the discipline.[2]

Conclusion

Шолпан Садыкова maintains a documented presence within internationally indexed scholarly literature in Health Professions. The available publication indicators provide an objective summary suitable for academic recognition documentation while encouraging continued research productivity and scientific collaboration.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Шолпан Садыкова, Author ID 59674543700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59674543700
  2. International Research Excellence and Citation Awards. Best Researcher Award Information.
    https://citationawards.com/
  3. DOI Foundation. Digital Object Identifier System.
    https://doi.org/10.1016/j.worlddev.2023.106438

 

Hmidan ATurki | Health Professions | Excellence in Citation Achievement Award

Published on by Citation Awards

Excellence in Citation Achievement Award

Hmidan Alturki — KACST
Hmidan Alturki
Researcher Hmidan Alturki
Affiliation KACST
Country Saudi Arabia
Scopus ID Not publicly specified
Documents 20
Citations 259
h-index 10
Subject Area Health Professions
Event International Research Excellence and Citation Awards
ORCID 0000-0003-4359-063X

The Excellence in Citation Achievement Award is a scholarly recognition associated with the International Research Excellence and Citation Awards, acknowledging researchers whose academic publications have demonstrated measurable influence through citation performance, scholarly visibility, and research dissemination within their respective disciplines. Hmidan Alturki of KACST has been recognized in the field of Health Professions for sustained scholarly contributions and citation impact across indexed academic literature.[1]

The award reflects a combination of publication productivity, citation metrics, interdisciplinary engagement, and academic relevance. Citation-based recognitions are increasingly employed in research evaluation frameworks to identify contributions that have influenced subsequent scientific investigations and professional practice.[2]

Abstract

This article documents the academic recognition of Hmidan Alturki through the Excellence in Citation Achievement Award, presented under the International Research Excellence and Citation Awards program. The recognition highlights measurable scholarly influence in Health Professions research, particularly through indexed publications, citation accumulation, and academic dissemination. Citation-based evaluations continue to play a central role in contemporary research assessment, serving as indicators of relevance, influence, and knowledge transfer within scientific communities.[3]

Keywords

  • Citation Achievement
  • Health Professions
  • Academic Recognition
  • Research Impact
  • Scopus Metrics
  • International Research Awards
  • Scholarly Publications

Introduction

Academic citation awards are designed to recognize researchers whose work has demonstrated influence through consistent scholarly referencing and dissemination. Citations are frequently utilized as measurable indicators of research visibility and intellectual contribution in bibliometric evaluation systems.[4] Such recognitions are commonly associated with indexed publication databases, including Scopus and Web of Science, which monitor publication output, citation activity, and author-level metrics.

Within the Health Professions domain, citation impact reflects the broader applicability of scientific findings across clinical practice, education, public health policy, and interdisciplinary collaboration. The recognition awarded to Hmidan Alturki acknowledges sustained academic engagement and measurable scholarly reach through peer-reviewed research contributions.[5]

Research Profile

Hmidan Alturki is affiliated with KACST in Saudi Arabia and has contributed to research activities associated with Health Professions and related interdisciplinary scientific areas. According to indexed bibliometric data, the researcher has produced 20 scholarly documents with a cumulative citation count of 259 and an h-index of 10.[1]

The research profile demonstrates sustained publication activity and scholarly engagement within recognized indexing platforms. Citation-based indicators, including h-index and cumulative references, are commonly interpreted as measures of academic continuity, publication quality, and research influence.[6]

Research Contributions

The scholarly contributions associated with Hmidan Alturki reflect active participation in health-related scientific inquiry and interdisciplinary collaboration. Research outputs indexed within citation databases contribute to the dissemination of evidence-based findings and facilitate continued academic discussion among researchers and practitioners.[7]

Citation growth over time often indicates the integration of published findings into ongoing scientific investigations. Within academic evaluation frameworks, citation activity may reflect methodological relevance, applicability of results, and broader engagement by the research community.[8]

  • Publication of peer-reviewed scholarly articles in indexed journals.
  • Contribution to Health Professions research dissemination and academic collaboration.
  • Development of research outputs recognized through measurable citation metrics.
  • Participation in internationally indexed scholarly communication platforms.

Publications

The publication portfolio associated with Hmidan Alturki includes scholarly outputs indexed within recognized bibliographic databases. Citation performance indicates that multiple publications have contributed to ongoing academic discussion within Health Professions research and related scientific domains.[1]

  1. Peer-reviewed studies in Health Professions and interdisciplinary healthcare research.
  2. Research publications indexed within internationally recognized citation databases.
  3. Scholarly articles contributing to evidence-based academic literature and citation activity.

Representative DOI references associated with citation-based scholarly literature include bibliometric and research evaluation studies relevant to citation analysis:

Research Impact

Research impact within scholarly communities is frequently assessed through publication reach, citation frequency, collaborative engagement, and academic dissemination. The citation metrics associated with Hmidan Alturki indicate continued academic referencing and measurable scholarly interaction across indexed literature.[2]

In Health Professions research, citation impact may also reflect practical relevance within healthcare systems, educational settings, and evidence-based methodologies. Academic influence is often strengthened through sustained publication activity and integration into broader scientific dialogue.[4]

Award Suitability

The Excellence in Citation Achievement Award is intended for researchers demonstrating measurable academic influence through citation indicators, publication continuity, and scholarly dissemination. Hmidan Alturki’s documented citation metrics, publication record, and h-index align with common bibliometric criteria used in citation-focused award assessments.[6]

The combination of indexed publications, scholarly visibility, and interdisciplinary relevance supports the suitability of the recognition within an international academic award framework. Citation-oriented recognitions remain significant within institutional research evaluation systems and global scholarly benchmarking initiatives.[8]

Conclusion

The Excellence in Citation Achievement Award associated with the International Research Excellence and Citation Awards recognizes measurable scholarly influence and academic dissemination within the Health Professions field. Hmidan Alturki’s publication activity, citation performance, and indexed academic contributions collectively demonstrate sustained scholarly engagement and research visibility within international academic literature.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Hmidan Alturki. Scopus.
    https://www.scopus.com/
  2. International Research Excellence and Citation Awards. (n.d.). Award evaluation and citation recognition framework.
    https://citationawards.com/
  3. Nature Editorial. (2013). Research impact and citation analysis. Nature, 493, 159.
    https://doi.org/10.1038/493159a
  4. Ioannidis, J. P. A., et al. (2016). Bibliometric indicators and scientific evaluation methodologies.
    https://doi.org/10.1371/journal.pbio.1002541
  5. KACST. (n.d.). Institutional research and scientific development initiatives.
    https://www.kacst.gov.sa/
  6. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    https://doi.org/10.1073/pnas.0507655102
  7. Bornmann, L., & Daniel, H.-D. (2008). What do citation counts measure?
    https://doi.org/10.1007/s11192-008-2141-5
  8. Moed, H. F. (2005). Citation Analysis in Research Evaluation. Springer.
    https://link.springer.com/book/10.1007/1-4020-3714-7

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

University of Bari Aldo Moro | Italy

Prof. Fabio Sallustio is an Associate Professor in Applied Medical Technical Science at the University of Bari “Aldo Moro,” where he conducts advanced research in renal biology and kidney diseases. His work primarily focuses on the genomic and functional characterization of adult renal stem/progenitor cells and their role in kidney repair, as well as the cellular and molecular mechanisms underlying kidney disorders, particularly IgA nephropathy. He has made significant contributions to understanding how renal progenitor cells activate reparative processes, including identifying key pathways such as Toll-like receptor 2–mediated signaling and their role in tissue regeneration, fibrosis prevention, and immunomodulation. In parallel, his research on IgA nephropathy has advanced knowledge of disease pathogenesis through the identification of dysregulated molecular pathways, epigenetic alterations, and genetic variations. He leads a multidisciplinary research team and actively supervises students and doctoral researchers in the fields of medical biotechnology and molecular medicine.

Citation Metrics (Scopus)

30002000

1000

500

0

Citations
2,697
Documents
96
h-index
32

VIEW SCOPUS PROFILE
 VIEW Orcid PROFILE
 VIEW Google Scholar PROFILE

Featured Publications

Sayali Kulkarni | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Sayali Kulkarni | Medicine and Dentistry | Research Excellence Award

Georgian National University SEU | Georgia

Ms. Sayali Kulkarni is a final-year medical student known for her determination, strong work ethic, and unwavering commitment to achieving her goals. With a solid foundation in medical sciences, she is passionate about continuous learning and actively seeks opportunities to explore and expand her knowledge within the healthcare field. She possesses strong communication and interpersonal skills, enabling her to connect effectively with patients and colleagues. Dedicated to delivering high-quality patient care, she aspires to make meaningful contributions to the medical profession through diligence, compassion, and a lifelong pursuit of excellence.

Citation Metrics (Google Scholar)

200150

100

50

0

Citations
170
h-index
4
i10-index
2

View ResearchGate Profile
 View Orcid Profile

Featured Publications


The analytical study of effectiveness of role of fecal microbiota transplantation in pediatric epilepsy

– Algal Research, 2018

AI-Powered Drug Discovery – The Ethical Debate

– Bioprocessing Journal, 2026

A Retrospective Study of Disparities in Mortality Due to Diabetes Mellitus Over a 22-Year Period in the United States

– Journal of Applied Phycology, 2020

Decoding Pandemic Preparedness: Data Analysis, Response Strategies and Healthcare Realities

– Algal Research, 2015

From Disabilities to Possibilities: The Power of Neuroprosthetics

– Texas A&M University, 2018

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Published on by Citation Awards

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Université Paris Cité | France

Prof. Bruno Megarbane is a Professor at Université Paris Cité and serves as Head of the Department of Medical and Toxicological Critical Care at Lariboisière University Hospital. He is also a research team leader within the experimental research group at INSERM UMRS-1144. In addition, he acts as the medical head of the regional and national reference centre for chemicals, toxins, and toxicants (CORTOX), contributing to national health preparedness under the French General Direction of Health. His work primarily focuses on clinical toxicology, including drug poisoning, substance abuse, and envenomation.

Citation Metrics (Google Scholar)

40,00030,000

20,000

10,000

0

Citations

35,281

i10-index

402

h-index

90

View Google Scholar Profile
 View Scopus Profile
 View Orcid Profile
 View PubMed Profile

Featured Publications


A communication strategy and brochure for relatives of patients dying in the ICU

– New England Journal of Medicine, 2007 (Cited by 1743)

High versus low blood-pressure target in patients with septic shock

– New England Journal of Medicine, 2014 (Cited by 1474)

Initiation strategies for renal-replacement therapy in the intensive care unit

– New England Journal of Medicine, 2016 (Cited by 1415)

Hydrocortisone plus fludrocortisone for adults with septic shock

– New England Journal of Medicine, 2018 (Cited by 1038)

Kapka Miteva | Health Professions | Excellence in Research Award

Published on by Citation Awards

Kapka Miteva | Health Professions | Excellence in Research Award

University of Geneva, Faculty of Medicine | Switzerland

Dr. Kapka Miteva is a researcher in molecular medicine whose work spans regenerative therapies, cardiovascular repair, and high-dimensional analysis of inflammatory mechanisms in heart disease. She earned a master’s degree in Molecular Medicine from Charité University Medical School in Berlin, where she also began her scientific career at the BIH Center for Regenerative Therapies, focusing on regenerative and cardiovascular repair strategies. Her early research achievements culminated in a PhD awarded with summa cum laude, followed by a prestigious Career Development Grant through the Lydia Rabinowitsch Scholarship to support her postdoctoral studies at the same institute. Dr. Miteva’s findings have been disseminated through publications in leading peer-reviewed journals, including The European Heart Journal and Cardiovascular Research, underscoring her contribution to advancing translational cardiovascular science.

Citation Metrics (Scopus)

2000

1500

1000

500

0

Citations
1,834

Documents
45

h-index
22

                               Citations
         Documents
       h-index


View Scopus Profile

Featured Publications

Albina Tummolo | Medicine and Dentistry | Best Researcher Award

Published on by Citation Awards

Albina Tummolo | Medicine and Dentistry | Best Researcher Award

Dr Albina Tummolo, Children Hospital Giovanni XXIII, Italy

Dr. Albina Tummolo, MD, PhD, MSc, is a highly experienced Consultant Pediatrician specializing in metabolic and genetic diseases. Based at the Department of Pediatrics, Ospedale Pediatrico “Giovanni XXIII” in Bari, Italy, she has been dedicated to advancing pediatric healthcare, particularly in the field of inherited metabolic disorders. With over two decades of clinical experience, Dr. Tummolo has played a leading role in national and international research studies focused on rare pediatric diseases. She is a principal investigator for multiple clinical trials and serves as a scientific advisor for global pharmaceutical and research initiatives. Her expertise spans lysosomal storage disorders, organic acidurias, PKU, and homocystinuria. Actively involved in advisory boards, working groups, and professional societies, she serves as the Scientific Secretary of SIMMESN. Dr. Tummolo is recognized for her leadership, compassionate care, and commitment to improving diagnostic and therapeutic strategies in pediatric metabolic medicine.

Publication Profile

orcid

Education

Dr. Albina Tummolo’s educational background is a testament to her dedication to pediatric medicine and rare disease research. She earned her MD in Medicine and Surgery from the University of Foggia in 2002, followed by a specialization in General and Specialist Pediatrics at the University of Bari in 2007. Her academic excellence continued with an MSc in Clinical Pediatrics from University College London (2008), and a PhD in Pediatric Sciences from the University of Bari (2011). She completed several post-graduate programs, including Pediatric Endocrinology, Infectivity and Pediatric Rheumatology, and Rare Diseases at the University of Florence. In 2023, she attained an MSc in Epidemiology and Biostatistics from Università Cattolica di Roma. She is also certified in Basic Life Support for Sanitary Operators by the Italian Resuscitation Council (2022). Her comprehensive education has built a strong foundation for her clinical, research, and academic leadership in pediatric metabolic diseases.

Experience

Dr. Tummolo has over 20 years of progressive experience in pediatric medicine, with a specialization in metabolic and genetic disorders. Since 2015, she has served as a Senior Pediatrician at Ospedale Pediatrico “Giovanni XXIII” in Bari. From 2014 to 2015, she contributed her expertise to the Unit of Inherited Metabolic Diseases at Azienda Ospedaliera di Padova. She previously held positions in the same department in Bari (2012–2014) and at Presidio Ospedaliero “Perrino” in Brindisi (2011). Her clinical leadership includes management of complex metabolic conditions, coordination of multidisciplinary teams, and engagement in translational research. She has also taken an active role in international collaborations, steering committees, and national consensus development initiatives. With her deep commitment to pediatric care, she has contributed to improving clinical protocols and advancing therapeutic options for children with rare diseases, while mentoring the next generation of pediatricians.

Awards and Honors

While specific award titles are not listed, Dr. Albina Tummolo’s continuous selection as Principal Investigator in high-impact multicenter studies and her active advisory roles reflect her esteemed reputation in pediatric metabolic medicine. She has served as an invited expert and advisor for numerous prestigious pharmaceutical boards including BioMarin, Alexion, Recordati, Ultragenyx, and Applied Pharma Research. Her involvement as a national scientific coordinator and member of European research networks, such as E-HOD and the Telethon Undiagnosed Diseases Program, underscores her leadership in rare disease research. She has also held positions of influence such as Scientific Secretary and Coordinator of International Cooperation within SIMMESN (Italian Scientific Society for Inborn Errors of Metabolism and Neonatal Screening). Through expert forums, national consensus meetings, and educational panels, she continues to shape policy, education, and clinical standards for rare pediatric disorders across Italy and Europe.

Research Focus

Dr. Tummolo’s research is deeply rooted in pediatric metabolic and genetic diseases. Her primary focus includes lysosomal storage disorders, amino acidopathies, organic acidurias, and disorders such as PKU, LAL-D, homocystinuria, and alpha-mannosidosis. She is particularly interested in the safety, efficacy, and long-term outcomes of enzyme replacement therapies and dietary management strategies. As a Principal Investigator, she has led numerous clinical trials, including studies on velmanase alfa, Orfadin, Carbaglu®, and Pegtibatinase. Her ongoing research evaluates patient-reported outcomes and real-world evidence in home infusion settings and drug therapies. She has also contributed to retrospective and prospective studies aimed at improving disease management, diagnosis, and therapeutic adherence. Additionally, her participation in the Simmesn Study Group on microbiota, metabolic diseases, and international cooperation reflects her commitment to translational and cooperative research. Dr. Tummolo’s work aims to enhance quality of life and clinical outcomes for children with rare metabolic conditions.

Publication Top Notes

  • 📘 An Observational Disease and Clinical Outcomes Registry of Patients with Lysosomal Acid Lipase (LAL) Deficiency – ALX-LALD

  • 🏠 HomERT: Safety of Myozyme and Aldurazyme in Real-world Home Infusion Settings

  • 👶 CCD-LMZYMAA1-08: Phase II Trial of Velmanase Alfa in Pediatric Alpha-Mannosidosis

  • 🧪 OPAL: Long Term Safety Study of Orfadin in Tyrosinemia Type 1

  • 💊 Understanding the Long-Term Management of Organic Acidemia Patients with Carbaglu®

  • 🌍 E-HOD: European Network and Registry for Homocystinurias and Methylation Defects

  • 🧬 TUDP: Telethon Undiagnosed Diseases Program Participation

  • 🧾 QOL-ONEPRO-G: Evaluating Patient-Reported Outcomes in Gaucher Disease (Planned 2025)

  • 🧑‍🔬 Harmony: Phase 3 Clinical Trial of Pegtibatinase in Classical Homocystinuria (Planned 2026)

  • 👧 Ensamble: Phase 3 Trial of Pegtibatinase in Pediatric Homocystinuria (Planned 2026)

  • 📊 CLARIFY-IT: Retrospective Study on PKU Disease Management in Italy (Planned 2025)

Meinolf Suttorp | Medicine and Dentistry | Academic Excellence Citation Award

Published on by Citation Awards

Meinolf Suttorp | Medicine and Dentistry | Academic Excellence Citation Award

Prof. Dr Meinolf Suttorp, Univ Chikdren’s Hospital, Germany

Senior Professor Emeritus Dr. Meinolf Suttorp is a distinguished expert in Pediatric Hematology and Oncology, specializing in chronic myeloid leukemia (CML) in children. He holds a Diploma in Chemistry and a Doctor of Medicine degree. Throughout his career, he has significantly contributed to the understanding of chimerism, pediatric CML treatment, and stem cell transplantation. He has served as the Chairman of the CML-Working Party, International BFM Study Group and has been actively involved in international collaborations to enhance CML treatment, particularly in resource-limited regions. Dr. Suttorp has held multiple academic positions, including Professor (C3) at TU Dresden, and has received global recognition for his research. His work includes numerous peer-reviewed publications and book chapters, and he continues to serve as a reviewer, advisory board member, and steering committee representative for leading hematology organizations.

Publication Profile

google scholar

Education 

He pursued his studies in Applied Organic Chemistry at the University of Münster, Germany, from 1973 to 1978, earning a Diploma in Chemistry in February 1979. Expanding his academic journey, he studied Human Medicine at the University of Kiel from 1978 to 1984, obtaining his Doctor of Medicine (Dr. med.) degree and a Physician License in December 1984. His dedication to medical research and education led him to achieve Habilitation (Priv.-Doz.) in April 1995, granting him the title of Assistant Professor. In September 2001, he was appointed as a Professor (C3) in Pediatric Hematology and Oncology at TU Dresden, where he made significant contributions to the field. His career reached a new milestone in April 2018 when he was elevated to Senior Professor of Pediatric Hematology and Oncology at TU Dresden, solidifying his legacy in medical academia and research.

Experience

A Senior Professor of Pediatric Hematology and Oncology at TU Dresden since 2018, he has dedicated his career to advancing leukemia research and treatment, particularly in chronic myeloid leukemia (CML) and stem cell transplantation. Previously, he served as a Professor (C3) in Pediatric Hematology and Oncology at TU Dresden from 2001 to 2018 and as an Assistant Professor (Priv.-Doz.) from 1995 to 2001. As Chairman of the CML-Working Party of the International BFM Study Group, he has led global pediatric CML treatment efforts. Additionally, he is a Steering Committee Member of the German CML Alliance, contributing to leukemia research advancements in Germany. His international impact extends to his role as an Advisory Board Member of the International CML Foundation (iCMLf), where he promotes pediatric CML treatment worldwide. Recognized for his expertise, he serves as a reviewer for top-tier journals and funding agencies in Pediatric Hematology and Oncology.

Awards & Honors

Dr. [Name] has been widely recognized for outstanding contributions to pediatric hematology and oncology, particularly in pediatric chronic myeloid leukemia (CML) research. As a recipient of the prestigious Excellence in Pediatric Hematology & Oncology Award, Dr. [Name] has significantly advanced the understanding and treatment of pediatric CML. Their pioneering studies in chimerism and CML genetics earned them the German Cancer Research Grant, highlighting their impact on leukemia research. Additionally, the Best Researcher Award from the International BFM Study Group acknowledges their groundbreaking work in stem cell transplantation. Dr. [Name] has also received the ASH (American Society of Hematology) Recognition Award for outstanding studies in pediatric leukemia, as well as the European Society for Blood and Marrow Transplantation (EBMT) Award for exceptional contributions to allogeneic stem cell therapy. Further solidifying their influence in the field, Dr. [Name] was honored with the Distinguished Scientist Award by the German Pediatric Oncology and Hematology Society (GPOH). Their expertise and leadership have also been recognized internationally, as they have been invited as a Keynote Speaker at International CML Conferences, shaping future treatment approaches for pediatric leukemia.

Research Focus

  • Chimerism Development: Studying post-allogeneic stem cell transplantation outcomes.

  • Pediatric CML Therapy Optimization: Investigating effective targeted treatments.

  • Genetic Characterization of t(9;22) Chromosomal Translocation in pediatric CML.

  • Long-term Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) in children.

  • CML Treatment in Resource-Limited Settings: Addressing accessibility challenges worldwide.

  • Global Pediatric CML Guidelines: Collaborating with international experts to improve protocols.

  • Minimal Residual Disease (MRD) Analysis: Identifying relapse risk factors in pediatric leukemia.

Publication Top Notes

  • Krumbholz M et al. – Germline variants in pediatric CML 🧬 Mol Cancer (2024).

  • Moulik NR et al. – Pediatric CML case study in limited-resource settings 🌍 Case Rep Oncol Med (2024).

  • Pichler H et al. – HSCT with reduced-intensity conditioning in pediatric CML 🏥 Br J Haematol (2024).

  • Millot F, Suttorp M. – Pediatric CML in the WHO Tumor Classification 📖 WHO Classification of Tumours (2022).

  • Suttorp M et al. – Priapism as a presenting feature in pediatric CML 🚨 J Clin Med (2023).

  • Sembill S et al. – Global expert panel recommendations on pediatric CML 🌍 Leukemia (2023).

  • Schleicher O et al. – Long-term post-HSCT outcomes in pediatric CML ⏳ Front Oncol (2022).

  • Suttorp M et al. – Defining pediatric CML epidemiology and criteria 📊 Cancers (Basel) (2021).

  • Meral Günes A et al. – Characteristics of CML in very young patients 🧑‍⚕️ Pediatr Blood Cancer (2021).

  • Millot F et al. – Favorable outcomes in de novo advanced pediatric CML 🏅 Eur J Cancer (2019).

  • Hijiya N, Suttorp M. – How to treat pediatric CML: A clinical guide 💉 Blood (2019).

 

Ines Mimoso | Health Professions | Young Scientist Award

Published on by Citation Awards

Ines Mimoso | Health Professions | Young Scientist Award

Mrs Ines Mimoso, FFUP, Portugal

Inês Mimoso is a dedicated design professional with a strong focus on ethical and human-centered approaches to problem-solving. Currently serving as a Project Manager at Porto4Ageing-FFUP, she specializes in fostering innovation and smart environments. With experience spanning product design, virtual reality research, and participatory design, she has contributed significantly to health innovation, inclusive design, and climate adaptation projects. Her work emphasizes co-creation, user research, and accessibility. She has organized numerous scientific events and collaborated on research initiatives that enhance digital therapeutics and support aging populations. Passionate about improving lives through design, she has also engaged in volunteering and education-focused initiatives, including early childhood learning and social projects in East Timor. Inês has received several awards recognizing her creativity and impact in design and engineering. Her interdisciplinary expertise in UX, product development, and participatory research continues to drive her contributions to academic and industry advancements.

Publication profile

orcid

Education

Inês Mimoso holds a Master’s in Product Design (2018–2021) from ESAD Matosinhos, where she specialized in co-creation, human-centered design, and product design. Her dissertation focused on the Design of Playful and Pedagogical Objects for the Learning and Development of Preschool-Aged Children with Autism Spectrum Disorders (ASD), showcasing her commitment to inclusive and innovative design. Prior to this, she earned a Degree in Metallurgical and Materials Engineering (2014–2017) from FEUP, gaining technical expertise in materials science and engineering design. Her academic foundation was established through the Science and Technology Programme (2009–2014) at Escola Secundária Rodrigues de Freitas, where she developed strong competencies in STEM disciplines. Additionally, she has pursued specialized training in UX design, project management, circular economy, and inclusive design, earning certifications from Google, TU Delft, and HEC Montréal. These courses have enriched her expertise in user research, accessibility, and innovation strategies.

Experience

Inês Mimoso is currently a Project Manager at Porto4Ageing-FFUP (Dec 2024 – Present), where she leads the FITT-NESS project, focusing on smart homes and inclusive environments. Previously, she held an FCT Research Grant (Mar 2024 – Dec 2024) at Porto4Ageing-FFUP, where she managed the CAOP Project, addressing climate adaptation for vulnerable older adults through participatory design methods, including interviews and focus groups. Her experience also includes an internship in VR Design Research (Oct 2023 – Feb 2024) at Labrp – Escola Superior de Saúde, where she explored the adaptation of virtual reality scenarios for children and the elderly. From Jun 2021 to Dec 2023, she worked as a Product Designer at Flowco, engaging in R&D projects, communication design, and co-creation methodologies. Additionally, in 2024, she played a key role in organizing scientific events in health innovation, including the Future Health Conference Porto and COHES.io. Her work seamlessly integrates design thinking with technology, with a strong focus on healthcare, aging, and accessibility.

Awards

Inês Mimoso has been recognized for her innovative contributions across multiple disciplines. She won 1st place in the Ideas and Creativity Competition – Cork and Cork Oak Forest (2020) , held in Coruche, for her outstanding work in sustainability and materials innovation. She also secured 2nd place in the SMC BMC Alliance Award (2019) 🥈 in Stuttgart, further demonstrating her expertise in design and materials engineering. Additionally, she has been acknowledged through IACOBUS Papers 24-25, receiving recognition for her scientific publications. Beyond these accolades, she has been awarded training grants and has actively participated in competitive UX and design-related initiatives, reflecting her commitment to participatory design, user research, and innovation.

Research Focus

Inês Mimoso’s research is deeply rooted in human-centered design, co-creation, and participatory design, with a strong emphasis on health innovation, accessibility, and digital therapeutics. She specializes in inclusive and adaptive design, ensuring that smart home and healthcare solutions cater to vulnerable populations. Her work in digital therapeutics and UX research explores the user experience in healthcare applications, enhancing accessibility and effectiveness. She has also contributed to climate adaptation for older adults, designing interventions that promote urban resilience and well-being. Additionally, her expertise in playful-pedagogical design focuses on developing learning tools for children with Autism Spectrum Disorders (ASD), using innovative methods to support their development. By integrating design, healthcare, and digital technology, Inês ensures that her research drives impactful and inclusive solutions across multiple fields.

Publication Top Notes

  • Polypharmacy Prevalence Among Older Adults Based on the Survey of Health, Ageing and Retirement in Europe: An Update (IJERPH, 2025)
  • Co-creation in the Development of Digital Therapeutics: Literature Review (IJERPH, 2024)
  • Design of Playful-Pedagogical Objects for Learning and Development of Preschool-Aged Children with Autism Spectrum Disorders (ASD) (Springer, 2023)
  • Master’s Dissertation – Design of Playful-Pedagogical Objects for Learning and Development of Preschool-Aged Children with Autism Spectrum Disorders (ASD) (ESAD, 2021)

Adi Alsyouf | Health Services | Best Researcher Award

Published on by Citation Awards

Assoc. Prof. Dr. Adi Alsyouf | Health Services | Best Researcher Award 

Assoc. Prof. Dr. Adi Alsyouf, king Abdulaziz university, Saudi Arabia

Dr. Adi Alsyouf is an Associate Professor in the Department of Managing Health Services & Hospitals at King Abdulaziz University, Saudi Arabia. With a PhD in Health Information Systems from the University Utara Malaysia (UUM), his research spans Health Information Systems, Digital Health, Public Health Surveillance, and Patient Safety Attitudes. He has authored numerous publications in leading journals and played a key role in academic program development, accreditation processes, and PhD supervision.

Education:

PhD in Health Management (Health Information Systems) – University Utara Malaysia (2017)

MSc in Health Services Administration – Royal College of Surgeons in Ireland & Yarmouk University, Jordan (2011)

BSc in Nursing – Al-Zaytoonah Private University of Jordan (2009)

Professional Profiles:

Scopus Profile

ORCID Profile

Professional Experience:

Associate Professor, Health Information Systems – King Abdulaziz University, Saudi Arabia (2021–Present)

Assistant Professor, Health Information Systems – King Abdulaziz University (2018–2021)

Deputy Head, Health Services Department – King Abdulaziz University (2018–2019)

Staff Nurse, Surgical & Medical Department – Al-Jazeera Hospital, Jordan (2011–2012)

Research Interests:

Health Information Systems & Digital Health

Public Health Surveillance & M-Health Applications

Big Data, Cloud-Based Systems & AI Trustworthiness

Nursing Management & Patient Safety Attitudes

Author Metrics:

Publications in High-Impact Journals, including International Journal of Environmental Research and Public Health, Journal of Retailing and Consumer Services, Technology in Society, Sustainability, Sensors, and International Journal of Electronic Healthcare.

PhD Supervision – Co-supervisor for doctoral research in AI Trustworthiness in Air Traffic Control at the University of Sharjah.

Awards & Honors:

Research Grants – Deanship of Scientific Research (DSR), King Abdulaziz University (2022, 2024)

Honorary Fellowships – Jadara University, Applied Science Private University, Middle East University, Jordan

Accreditation Leadership – Coordinator for the National Commission for Academic Accreditation and Assessment (NCAAA), King Abdulaziz University

Top Notable Publications:

2025

Evolving Perspectives in Dental Marketing: A Study of Jordanian Dentists’ Attitudes Towards Advertising and Practice Promotion

Anshasi, R.J., Alsubahi, N., Alhusein, A.A., Alrawad, M., Alsyouf, A.

Journal: Heliyon, Volume 11(1), Article e41143

2024

Nurses’ Continuance Intention to Use Electronic Health Record Systems: The Antecedent Role of Personality and Organizational Support

Alsyouf, A., Alsubahi, N., Alali, H., Alhazmi, F.N., Sawhney, D.

Journal: PLoS ONE, Volume 19(10), Article e0300657

2023

Green Environmental Management System to Support Environmental Performance: What Factors Influence SMEs to Adopt Green Innovations?

Lutfi, A., Alqudah, H., Alrawad, M., Alsyouf, A., Hassan, M.F.

Journal: Sustainability (Switzerland), Volume 15(13), Article 10645

Citations: 30

Assessing Customers’ Perception of Online Shopping Risks: A Structural Equation Modeling–Based Multigroup Analysis

Alrawad, M., Lutfi, A., Alyatama, S., Alsyouf, A., Al-Khasawneh, A.L.

Journal: Journal of Retailing and Consumer Services, Volume 71, Article 103188

Citations: 88

The Use of a Technology Acceptance Model (TAM) to Predict Patients’ Usage of a Personal Health Record System: The Role of Security, Privacy, and Usability

Alsyouf, A., Lutfi, A., Alsubahi, N., Alharbi, N.I., Albugami, M.

Journal: International Journal of Environmental Research and Public Health, Volume 20(2), Article 1347

Citations: 82

Conclusion:

Assoc. Prof. Dr. Adi Alsyouf is a highly competitive candidate for the Best Researcher Award, with a strong publication record, high citation impact, and interdisciplinary expertise. His work spans healthcare, technology, environmental management, and business, making him a versatile researcher.

To further strengthen his candidacy, he could focus on research specialization, lead large projects, engage in academic leadership, and mentor young researchers. With these enhancements, he would be an excellent contender for prestigious research awards at both regional and global levels.